TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase. (Q53090999)

11 May 2018

title

TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase. (English)

1 reference

11 May 2018

inflammatory breast cancer

main subject

inflammation

0 references

1 reference

10

1 reference

11 May 2018

Wendy A Woodward

Wendy A Woodward

7

0 references

Gabriel N Hortobagyi

11

Gabriel N Hortobagyi

1 reference

11 May 2018

Mien-Chie Hung

12

Mien-Chie Hung

1 reference

11 May 2018

Weiya Xia

4

Weiya Xia

1 reference

11 May 2018

Hitomi Saso

2

Hitomi Saso

1 reference

11 May 2018

author name string

Xiaoping Wang

1

1 reference

11 May 2018

Takayuki Iwamoto

3

1 reference

11 May 2018

Yun Gong

5

1 reference

11 May 2018

Lajos Pusztai

6

1 reference

11 May 2018

James M Reuben

8

1 reference

11 May 2018

Steven L Warner

9

1 reference

11 May 2018

Naoto T Ueno

13

1 reference

11 May 2018

language of work or name

English

0 references

publication date

6 September 2013

1 reference

11 May 2018

published in

Cancer Research

1 reference

11 May 2018

volume

73

1 reference

11 May 2018

issue

21

1 reference

11 May 2018

page(s)

6516-6525

1 reference

11 May 2018

Molecular characterisation of cell line models for triple-negative breast cancers

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Hyperosmotic stress induces Axl activation and cleavage in cerebral endothelial cells

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Tumor metastasis: mechanistic insights and clinical challenges

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Discovery of epigenetically masked tumor suppressor genes in endometrial cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Update on the management of inflammatory breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Recent developments in receptor-selective retinoids

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Inflammatory breast cancer: a review

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

The humoral immune system has a key prognostic impact in node-negative breast cancer

2 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24014597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Aberrant promoter hypermethylation of tazarotine-induced gene 1 (TIG1) in head and neck cancer]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24014597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Trends for Inflammatory Breast Cancer: Is Survival Improving?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24014597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-13-0967

1 reference

11 May 2018

PMC publication ID

6135947

0 references

1 reference

11 May 2018